Bayrak EBT Valuation
| BAYRK Stock | TRY 17.91 0.03 0.17% |
At this time, the firm appears to be overvalued. Bayrak EBT Taban shows a prevailing Real Value of 15.23 per share. The current price of the firm is 17.91. Our model approximates the value of Bayrak EBT Taban from analyzing the firm fundamentals such as Return On Equity of 6.37, current valuation of 227.89 M, and Profit Margin of 6.17 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bayrak EBT's price fluctuation is not too volatile at this time. Calculation of the real value of Bayrak EBT Taban is based on 3 months time horizon. Increasing Bayrak EBT's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bayrak EBT is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bayrak Stock. However, Bayrak EBT's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.91 | Real 15.23 | Hype 17.91 | Naive 17.45 |
The intrinsic value of Bayrak EBT's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Bayrak EBT's stock price.
Estimating the potential upside or downside of Bayrak EBT Taban helps investors to forecast how Bayrak stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bayrak EBT more accurately as focusing exclusively on Bayrak EBT's fundamentals will not take into account other important factors: Bayrak EBT Total Value Analysis
Bayrak EBT Taban is currently forecasted to have takeover price of 227.89 M with market capitalization of 182.37 M, debt of 29.16 M, and cash on hands of 11.2 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bayrak EBT fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
227.89 M | 182.37 M | 29.16 M | 11.2 M |
Bayrak EBT Investor Information
About 45.0% of the company shares are held by company insiders. The book value of Bayrak EBT was currently reported as 2.35. The company had not issued any dividends in recent years. Based on the key indicators related to Bayrak EBT's liquidity, profitability, solvency, and operating efficiency, Bayrak EBT Taban is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Bayrak EBT Asset Utilization
One of the ways to look at asset utilization of Bayrak is to check how much profit was generated for every dollar of assets it reports. Bayrak EBT Taban utilizes its assets nearly 4.72 percent, earning 0.0472 for each lira of assets held by the firm. A positive asset utilization signifies that the company is slightly more effective with each lira of assets it shows. Put another way, asset utilization of Bayrak EBT shows how effective it operates for each lira spent on its assets.Bayrak EBT Ownership Allocation
Bayrak EBT holds a total of 23.56 Million outstanding shares. Bayrak EBT Taban retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Bayrak EBT Profitability Analysis
The company reported the revenue of 54.85 M. Net Income was 3.39 M with profit before overhead, payroll, taxes, and interest of 9.85 M.About Bayrak EBT Valuation
An absolute valuation paradigm, as applied to Bayrak Stock, attempts to find the value of Bayrak EBT Taban based on its fundamental and basic technical indicators. By analyzing Bayrak EBT's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Bayrak EBT's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bayrak EBT. We calculate exposure to Bayrak EBT's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bayrak EBT's related companies.Bayrak Ebt Taban Sanayi Ve Ticaret Anonim Sirketi engages in manufacturing PVC and thermo shoe soles for various brands. BAYRAK TABAN operates under Footwear Accessories classification in Turkey and is traded on Istanbul Stock Exchange. It employs 280 people.
8 Steps to conduct Bayrak EBT's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bayrak EBT's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bayrak EBT's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bayrak EBT's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bayrak EBT's revenue streams: Identify Bayrak EBT's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bayrak EBT's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bayrak EBT's growth potential: Evaluate Bayrak EBT's management, business model, and growth potential.
- Determine Bayrak EBT's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bayrak EBT's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Bayrak Stock analysis
When running Bayrak EBT's price analysis, check to measure Bayrak EBT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayrak EBT is operating at the current time. Most of Bayrak EBT's value examination focuses on studying past and present price action to predict the probability of Bayrak EBT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayrak EBT's price. Additionally, you may evaluate how the addition of Bayrak EBT to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |